THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS;G1 THERAPEUTICS INC.
发明人:
申请号：
IL26779519
公开号：
IL267795D0
申请日:
2019.07.02
申请国别(地区):
IL
年份:
2019
代理人:
摘要：
Compositions, combinations and methods comprising a CDK4/6 inhibitor of Formula D with a selective estrogen receptor downregulator of Formula A, B or C that are advantageous for the treatment of abnormal cellular proliferation, including a cancer or a tumor.
